TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
Octapharma AS
Closing information (x1000 DKK)
| Closing information | 2023/12 | 2022/12 | 2021/12 |
| Turnover |
97,835
|
303,077
|
326,548 |
| Financial expenses |
1
|
3
|
0 |
| Earnings before taxes |
4,071
|
9,855
|
11,774 |
| Total assets |
26,368
|
91,210
|
109,246 |
| Current assets |
26,227
|
91,150
|
109,185 |
| Current liabilities |
7,619
|
35,764
|
58,838 |
| Equity capital |
18,749
|
55,447
|
50,408 |
| - share capital |
99
|
106
|
112 |
Financial ratios
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Solvency |
71.1%
|
60.8%
|
46.1% |
| Turnover per employee | |||
| Profit as a percentage of turnover |
4.2%
|
3.3%
|
3.6% |
| Return on assets (ROA) |
15.4%
|
10.8%
|
10.8% |
| Current ratio |
344.2%
|
254.9%
|
185.6% |
| Return on equity (ROE) |
21.7%
|
17.8%
|
23.4% |
| Change turnover |
-186,619
|
-6,318
|
62,515 |
| Change turnover % |
-66%
|
-2%
|
24% |
| Chg. No. of employees | |||
| Chg. No. of employees % |
Total value of public sale
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.